Xenon Pharmaceuticals registers additional shares under its 2025 Inducement Equity Incentive Plan, enhancing employee compensation strategies.
| Name | Xenon Pharmaceuticals Inc. |
|---|---|
| CIK | 0001582313 |
| Tickers | XENE |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 980661854 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | A1 British Columbia, Canada |
| Phone | (604) 484-3300 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Xenon Pharmaceuticals registers additional shares under its 2025 Inducement Equity Incentive Plan, enhancing employee compensation strategies.
Xenon Pharmaceuticals Inc. shares its Q3 results, highlighting advancements in its pharmaceutical pipeline and ongoing commitment to research and development.
FMR LLC's updated filing reveals an 11.5% stake in Xenon Pharmaceuticals, indicating growing investor interest in the pharmaceutical sector.
Xenon Pharmaceuticals CFO Kelly Thomas Patrick acquires 15,000 shares, signaling confidence in the company's future amid the pharmaceutical preparations sector.
806 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005106 | 005-88403 | 261556368 | 34 | 9302 | |||
| 2026-11-09 | S-8 | S-8 | 0001193125-26-453723 | 333-299931 | 261536575 | 33 | 391685 | 1 | 1 | |
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-453701 | 001-36687 | 261536490 | 34 | 11219292 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-453521 | 001-36687 | 261535752 | 34 | 478028 | 1 | 1 |
| 2026-11-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000704 | 005-88403 | 261530264 | 34 | 7664 | |||
| 2026-11-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000699 | 005-88403 | 261530163 | 34 | 7531 | |||
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002888 | 005-88403 | 261526352 | 34 | 11728 | |||
| 2026-10-16 | 4 | 4 | 0001193125-26-424428 | 7076 | ||||||
| 2026-10-01 | 4 | 4 | 0001193125-26-410001 | 4654 | ||||||
| 2026-10-01 | 4 | 4 | 0001193125-26-409999 | 5354 | ||||||
| 2026-09-03 | 4 | 4 | 0001193125-26-382412 | 6907 | ||||||
| 2026-08-31 | 4 | 4 | 0001193125-26-377309 | 7879 | ||||||
| 2026-08-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008816 | 001-36687 | 261340624 | 33 | 4969 | |||
| 2026-08-13 | 4 | 4 | 0001193125-26-349351 | 5293 | ||||||
| 2026-08-13 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-349336 | 001-36687 | 261274052 | 33 | 5231 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902219-26-000248 | 005-88403 | 261273323 | 34 | 15442 | |||
| 2026-08-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002245 | 005-88403 | 261252380 | 34 | 11714 | |||
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-338244 | 001-36687 | 261249722 | 34 | 10151852 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-338019 | 001-36687 | 261249138 | 34 | 464350 | 1 | 1 |
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002171 | 005-88403 | 261247277 | 34 | 11711 | |||
| 2026-06-08 | 4 | 4 | 0001193125-26-262672 | 5846 | ||||||
| 2026-06-08 | 4 | 4 | 0001193125-26-262671 | 4950 | ||||||
| 2026-06-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005712 | 001-36687 | 261069668 | 33 | 4799 | |||
| 2026-06-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005710 | 001-36687 | 261069659 | 33 | 4827 | |||
| 2026-06-03 | 4 | 4 | 0001193125-26-256126 | 12346 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-256125 | 11511 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-256124 | 11466 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-256122 | 11470 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-256121 | 13332 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-256120 | 11450 | ||||||
| 2026-06-03 | 4 | 4 | 0001193125-26-256118 | 13366 | ||||||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255544 | 333-216543 | 261061078 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255539 | 333-279962 | 261061058 | 33 | 435449 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255530 | 333-265377 | 261061033 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255521 | 333-238895 | 261061003 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255517 | 333-237036 | 261060984 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255510 | 333-230103 | 261060957 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255504 | 333-223497 | 261060930 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255486 | 333-210050 | 261060876 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255452 | 333-202765 | 261060729 | 33 | 435452 | |||
| 2026-06-03 | S-8 POS | S-8 POS | 0001193125-26-255442 | 333-199860 | 261060698 | 33 | 435549 | |||
| 2026-06-03 | S-8 | S-8 | 0001193125-26-255419 | 333-296457 | 261060622 | 33 | 407735 | 1 | 1 | |
| 2026-06-03 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-26-255396 | 001-36687 | 261060533 | 34 | 971182 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001274173-26-000118 | 005-88403 | 26984204 | 34 | 12099 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-002464 | 005-88403 | 26982491 | 34 | 10663 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000938206-26-000027 | 005-88403 | 26982179 | 34 | 7211 | |||
| 2026-05-13 | 4 | 4 | 0001193125-26-222369 | 6896 | ||||||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-212153 | 001-36687 | 26954188 | 34 | 8889649 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-211843 | 001-36687 | 26952996 | 34 | 380206 | 1 | 1 |
| 2026-04-22 | ARS | ARS | 0001193125-26-170361 | 001-36687 | 26883733 | 34 | 2803695 | |||
| 2026-04-22 | DEFA14A | DEFA14A | 0001193125-26-170335 | 001-36687 | 26883690 | 34 | 866971 | 1 | 1 | |
| 2026-04-22 | DEF 14A | DEF 14A | 0001193125-26-170320 | 001-36687 | 26883659 | 34 | 7178844 | 1 | 1 | |
| 2026-04-13 | S-8 | S-8 | 0001193125-26-152844 | 333-295020 | 26857837 | 33 | 404772 | 1 | 1 | |
| 2026-04-13 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-152834 | 001-36687 | 26857796 | 34 | 742558 | 1 | 1 |
| 2026-03-13 | 4 | 4 | 0001193125-26-106727 | 8600 | ||||||
| 2026-03-13 | 4 | 4 | 0001193125-26-106726 | 8569 | ||||||
| 2026-03-13 | 4 | 4 | 0001193125-26-106724 | 9310 | ||||||
| 2026-03-13 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-106682 | 001-36687 | 26754005 | 33 | 5154 | |||
| 2026-03-13 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-106681 | 001-36687 | 26754002 | 33 | 5121 | |||
| 2026-03-13 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-106680 | 001-36687 | 26753999 | 33 | 6438 | |||
| 2026-03-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-106144 | 001-36687 | 26752527 | 34 | 191773 | 1 | 1 |
| 2026-03-12 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-104199 | 001-36687 | 26748002 | 34 | 648436 | 1 | 1 |
| 2026-03-12 | 424B5 | 424B5 | 0001193125-26-102517 | 333-281451 | 26744703 | 33 | 679498 | 1 | 1 | |
| 2026-03-11 | 4 | 4 | 0001193125-26-102669 | 10773 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102667 | 10742 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102666 | 43351 | ||||||
| 2026-03-11 | FWP | FWP | 0001193125-26-100831 | 333-281451 | 26741345 | 34 | 92624 | |||
| 2026-03-10 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-100805 | 001-36687 | 26741314 | 33 | 4517 | |||
| 2026-03-10 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-100799 | 001-36687 | 26741304 | 33 | 4550 | |||
| 2026-03-10 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-100797 | 001-36687 | 26741303 | 33 | 5835 | |||
| 2026-03-09 | 424B5 | 424B5 | 0001193125-26-098764 | 333-281451 | 26735884 | 33 | 504715 | |||
| 2026-03-09 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-098734 | 001-36687 | 26735768 | 33 | 5226 | |||
| 2026-03-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-097577 | 001-36687 | 26733202 | 34 | 11513078 | 1 | 1 |
| 2026-02-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-082520 | 001-36687 | 26699511 | 34 | 1147911 | 1 | 1 |
| 2026-02-27 | 424B5 | 424B5 | 0001193125-26-082504 | 333-281451 | 26699465 | 33 | 620577 | 1 | 1 | |
| 2026-02-26 | 10-K | 10-K | 0001193125-26-076650 | 001-36687 | 26688172 | 34 | 16934986 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-076530 | 001-36687 | 26687682 | 34 | 421803 | 1 | 1 |
| 2026-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-26-000084 | 005-88403 | 26614316 | 34 | 17062 | |||
| 2026-01-09 | 4 | 4 | 0001193125-26-009238 | 7521 | ||||||
| 2026-01-09 | 4 | 4 | 0001193125-26-009235 | 7557 | ||||||
| 2026-01-09 | 4 | 4 | 0001193125-26-009232 | 7487 | ||||||
| 2026-01-09 | 4 | 4 | 0001193125-26-009230 | 7539 | ||||||
| 2026-01-02 | 4 | 4 | 0001193125-26-001172 | 11589 | ||||||
| 2026-01-02 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-001168 | 001-36687 | 26503434 | 33 | 6402 | |||
| 2025-12-09 | 4 | 4 | 0001193125-25-313147 | 10074 | ||||||
| 2025-12-08 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-311409 | 001-36687 | 251556915 | 33 | 7292 | |||
| 2025-12-05 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-310009 | 001-36687 | 251554084 | 33 | 5718 | |||
| 2025-12-03 | 4 | 4 | 0001193125-25-307211 | 5447 | ||||||
| 2025-12-01 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-304226 | 001-36687 | 251541266 | 33 | 5113 | |||
| 2025-12-01 | S-8 | S-8 | 0001193125-25-303888 | 333-291868 | 251539781 | 33 | 457654 | 1 | 1 | |
| 2025-12-01 | 8-K | 8-K | 5.02,9.01 | 0001193125-25-303862 | 001-36687 | 251539648 | 34 | 741396 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000274 | 005-88403 | 251482368 | 34 | 9390 | |||
| 2025-11-03 | 10-Q | 10-Q | 0001193125-25-262646 | 001-36687 | 251444614 | 34 | 9095174 | 1 | 1 | |
| 2025-11-03 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-262519 | 001-36687 | 251444015 | 34 | 438794 | 1 | 1 |
| 2025-10-17 | 4 | 4 | 0001193125-25-242700 | 7528 | ||||||
| 2025-10-17 | 3 | 3 | 0001193125-25-242698 | 15726 | ||||||
| 2025-10-17 | 8-K/A | 8-K/A | 5.02,8.01,9.01 | 0001193125-25-242583 | 001-36687 | 251401248 | 34 | 1402381 | 1 | 1 |
| 2025-10-16 | 8-K | 8-K | 5.02 | 0001193125-25-241546 | 001-36687 | 251398377 | 34 | 1400841 | 1 | 1 |
| 2025-10-01 | 4 | 4 | 0001193125-25-227202 | 9595 | ||||||
| 2025-10-01 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-227196 | 001-36687 | 251366095 | 33 | 4593 | |||
| 2025-09-19 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-209529 | 001-36687 | 251328256 | 33 | 4289 | |||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902219-25-000271 | 005-88403 | 251204910 | 34 | 15317 | |||
| 2025-08-11 | 10-Q | 10-Q | 0000950170-25-106599 | 001-36687 | 251202501 | 34 | 9904913 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-106529 | 001-36687 | 251201939 | 34 | 439207 | 1 | 1 |
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002142 | 005-88403 | 251188515 | 34 | 11179 | |||
| 2025-07-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002959 | 005-88403 | 251132117 | 34 | 10992 | |||
| 2025-07-03 | 8-K | 8-K | 5.02 | 0000950170-25-093996 | 001-36687 | 251106399 | 34 | 163338 | 1 | 1 |
| 2025-06-24 | 4 | 4 | 0000950170-25-089721 | 5182 | ||||||
| 2025-06-24 | 3 | 3 | 0000950170-25-089718 | 15382 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083329 | 7245 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083328 | 7464 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083325 | 7372 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083323 | 7423 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083321 | 9003 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083318 | 7405 | ||||||
| 2025-06-06 | 4 | 4 | 0000950170-25-083317 | 7480 | ||||||
| 2025-06-05 | 8-K | 8-K | 5.07,9.01 | 0000950170-25-082494 | 001-36687 | 251028036 | 34 | 239357 | 1 | 1 |
| 2025-05-16 | 4 | 4 | 0000950170-25-073746 | 6548 | ||||||
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-069342 | 001-36687 | 25935543 | 34 | 7871013 | 1 | 1 | |
| 2025-05-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-069183 | 001-36687 | 25934806 | 34 | 382067 | 1 | 1 |
| 2025-04-24 | ARS | ARS | 0000950170-25-058092 | 001-36687 | 25867676 | 34 | 1301535 | |||
| 2025-04-24 | DEFA14A | DEFA14A | 0000950170-25-058088 | 001-36687 | 25867663 | 34 | 909046 | 1 | 1 | |
| 2025-04-24 | DEF 14A | DEF 14A | 0000950170-25-058086 | 001-36687 | 25867658 | 34 | 6768651 | 1 | 1 | |
| 2025-03-17 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-040381 | 001-36687 | 25745145 | 34 | 216566 | 1 | 1 |
| 2025-03-13 | 4 | 4 | 0000950170-25-039025 | 7447 | ||||||
| 2025-03-13 | 4 | 4 | 0000950170-25-039021 | 7427 | ||||||
| 2025-03-13 | 4 | 4 | 0000950170-25-039020 | 7428 | ||||||
| 2025-03-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000993 | 005-88403 | 25717955 | 34 | 11507 | |||
| 2025-03-05 | 8-K | 8-K | 4.01,9.01 | 0000950170-25-033653 | 001-36687 | 25711529 | 34 | 180484 | 1 | 1 |
| 2025-02-27 | S-8 | S-8 | 0000950170-25-029256 | 333-285382 | 25681010 | 33 | 450910 | 1 | 1 | |
| 2025-02-27 | 10-K | 10-K | 0000950170-25-029149 | 001-36687 | 25679892 | 34 | 16763145 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,5.02,7.01,9.01 | 0000950170-25-029010 | 001-36687 | 25678618 | 34 | 431064 | 1 | 1 |
| 2025-01-27 | 4 | 4 | 0000950170-25-009388 | 23665 | ||||||
| 2025-01-27 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-009384 | 001-36687 | 25560625 | 33 | 5716 | |||
| 2025-01-24 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-008888 | 001-36687 | 25555109 | 33 | 5109 | |||
| 2025-01-23 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-008446 | 001-36687 | 25551243 | 33 | 4501 | |||
| 2025-01-17 | 8-K | 8-K | 5.02 | 0000950170-25-006495 | 001-36687 | 25537144 | 34 | 166922 | 1 | 1 |
| 2024-12-19 | 4 | 4 | 0000950170-24-138629 | 16245 | ||||||
| 2024-12-18 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-138009 | 001-36687 | 241560449 | 33 | 4076 | |||
| 2024-11-22 | 4 | 4 | 0000950170-24-130378 | 16359 | ||||||
| 2024-11-22 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-130340 | 001-36687 | 241491338 | 33 | 3967 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-125547 | 001-36687 | 241449081 | 34 | 6194262 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-125374 | 001-36687 | 241448125 | 34 | 363986 | 1 | 1 |
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002938 | 005-88403 | 241445050 | 34 | 8197 | |||
| 2024-08-09 | S-3ASR | S-3ASR | 0000950170-24-094855 | 333-281451 | 241193747 | 33 | 1198723 | 1 | 1 | |
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-094109 | 001-36687 | 241189091 | 34 | 6157497 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-093933 | 001-36687 | 241188307 | 34 | 362075 | 1 | 1 |
| 2024-07-12 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-083357 | 001-36687 | 241115724 | 33 | 11105 | |||
| 2024-06-12 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-072572 | 001-36687 | 241039432 | 33 | 5827 | |||
| 2024-06-05 | 4 | 4 | 0000950170-24-069468 | 14521 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069467 | 14750 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069466 | 14652 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069465 | 5183 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069464 | 5157 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069463 | 14690 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069462 | 14763 | ||||||
| 2024-06-05 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-069439 | 001-36687 | 241023128 | 33 | 6766 | |||
| 2024-06-05 | S-8 | S-8 | 0000950170-24-069340 | 333-279962 | 241022283 | 33 | 230962 | |||
| 2024-06-05 | 8-K | 8-K | 5.07,9.01 | 0000950170-24-069318 | 001-36687 | 241022136 | 34 | 629718 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-057139 | 001-36687 | 24931367 | 34 | 5684830 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-056940 | 001-36687 | 24930621 | 34 | 308719 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0000950170-24-049201 | 001-36687 | 24884262 | 34 | 1158931 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049198 | 001-36687 | 24884236 | 34 | 4941151 | 1 | 1 | |
| 2024-04-19 | 8-K | 8-K | 5.02 | 0000950170-24-046023 | 001-36687 | 24858048 | 34 | 162259 | 1 | 1 |
| 2024-03-12 | 4 | 4 | 0000950170-24-030250 | 14743 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030245 | 14696 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030239 | 14743 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030236 | 14717 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030233 | 14777 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030228 | 14720 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030226 | 14749 | ||||||
| 2024-03-11 | 4 | 4 | 0000950170-24-029542 | 19301 | ||||||
| 2024-03-08 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-028834 | 001-36687 | 24736123 | 33 | 4152 | |||
| 2024-03-08 | 4 | 4 | 0000950170-24-028795 | 26978 | ||||||
| 2024-03-08 | 4 | 4 | 0000950170-24-028788 | 19163 | ||||||
| 2024-03-08 | 8-K | 8-K | 8.01,9.01 | 0000950170-24-028784 | 001-36687 | 24735697 | 34 | 188374 | 1 | 1 |
| 2024-03-07 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-028232 | 001-36687 | 24731916 | 33 | 4135 | |||
| 2024-03-07 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-028231 | 001-36687 | 24731912 | 33 | 4176 | |||
| 2024-02-29 | 10-K | 10-K | 0000950170-24-023177 | 001-36687 | 24704412 | 34 | 11140458 | 1 | 1 | |
| 2024-02-29 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-023080 | 001-36687 | 24703702 | 34 | 369624 | 1 | 1 |
| 2024-02-14 | SC 13G/A | XENON PHARMACEUTICALS, INC. | 0000902664-24-001599 | 005-88403 | 24632941 | 34 | 60224 | |||
| 2024-02-14 | SC 13G/A | schedule13g.htm | 0000938206-24-000006 | 005-88403 | 24632356 | 34 | 51857 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001592 | 005-88403 | 24612681 | 34 | 8202 | |||
| 2024-02-08 | SC 13G | SEC SCHEDULE 13G | 0000902219-24-000018 | 005-88403 | 24607209 | 34 | 37599 | |||
| 2024-01-02 | 4 | 4 | 0000950170-24-000304 | 4816 | ||||||
| 2023-12-20 | 4 | 4 | 0000950170-23-071929 | 10565 | ||||||
| 2023-12-15 | 4/A | 4/A | 0000950170-23-070912 | 5661 | ||||||
| 2023-12-15 | 4 | 4 | 0000950170-23-070841 | 26153 | ||||||
| 2023-12-14 | 144 | xsl144X01/primary_doc.xml | 0001959173-23-005475 | 001-36687 | 231487083 | 33 | 5263 | |||
| 2023-12-13 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-070146 | 001-36687 | 231485302 | 33 | 4161 | |||
| 2023-11-30 | 424B5 | 424B5 | 0000950170-23-067043 | 333-260010 | 231456098 | 33 | 1101128 | |||
| 2023-11-30 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-23-067040 | 001-36687 | 231456039 | 34 | 940858 | 1 | 1 |
| 2023-11-29 | 424B5 | 424B5 | 0000950170-23-066819 | 333-260010 | 231453144 | 33 | 1058340 | |||
| 2023-11-27 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-066032 | 001-36687 | 231437301 | 34 | 209729 | 1 | 1 |
| 2023-11-09 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-062022 | 001-36687 | 231392351 | 34 | 201468 | 1 | 1 |
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-061200 | 001-36687 | 231388561 | 34 | 8355350 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-061119 | 001-36687 | 231387968 | 34 | 436461 | 1 | 1 |
| 2023-08-24 | 4 | 4 | 0000950170-23-044403 | 4925 | ||||||
| 2023-08-24 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-044389 | 001-36687 | 231202520 | 33 | 4229 | |||
| 2023-08-10 | 4 | 4 | 0000950170-23-041534 | 5170 | ||||||
| 2023-08-10 | 3 | 3 | 0000950170-23-041531 | 13483 | ||||||
| 2023-08-10 | 4 | 4 | 0000950170-23-041528 | 5203 | ||||||
| 2023-08-10 | 3 | 3 | 0000950170-23-041524 | 13230 | ||||||
| 2023-08-09 | 10-Q | 10-Q | 0000950170-23-040681 | 001-36687 | 231155815 | 34 | 9169123 | 1 | 1 | |
| 2023-08-09 | 8-K | 8-K | 2.01,7.01,9.01 | 0000950170-23-040608 | 001-36687 | 231155378 | 34 | 478786 | 1 | 1 |
| 2023-08-08 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-039782 | 001-36687 | 231151260 | 34 | 214972 | 1 | 1 |
| 2023-06-02 | 4 | 4 | 0000950170-23-026195 | 5069 | ||||||
| 2023-06-02 | 4 | 4 | 0000950170-23-026190 | 4926 | ||||||
| 2023-06-02 | 4 | 4 | 0000950170-23-026184 | 5078 | ||||||
| 2023-06-02 | 4 | 4 | 0000950170-23-026178 | 5161 | ||||||
| 2023-06-02 | 4 | 4 | 0000950170-23-026171 | 5104 | ||||||
| 2023-06-02 | 4 | 4 | 0000950170-23-026169 | 4904 | ||||||
| 2023-06-02 | 4 | 4 | 0000950170-23-026167 | 5203 | ||||||
| 2023-06-02 | 8-K | 8-K | 5.07 | 0000950170-23-026070 | 001-36687 | 23988742 | 34 | 282766 | 1 | 1 |
| 2023-06-01 | 4 | 4 | 0000950170-23-025802 | 35881 | ||||||
| 2023-06-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-025799 | 001-36687 | 23986196 | 33 | 6577 | |||
| 2023-05-31 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-025496 | 001-36687 | 23982730 | 33 | 6543 | |||
| 2023-05-30 | 144 | xsl144X01/primary_doc.xml | 0000950170-23-025011 | 001-36687 | 23978504 | 33 | 4641 | |||
| 2023-05-26 | 4 | 4 | 0000950170-23-024600 | 25133 | ||||||
| 2023-05-24 | 144 | xsl144X01/primary_doc.xml | 0001193125-23-153154 | 001-36687 | 23955515 | 33 | 4518 | |||
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019775 | 001-36687 | 23902775 | 34 | 7623836 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-019727 | 001-36687 | 23902445 | 34 | 393970 | 1 | 1 |
| 2023-04-27 | ARS | ARS | 0000950170-23-015298 | 001-36687 | 23857288 | 34 | 853207 | |||
| 2023-04-27 | DEF 14A | DEF 14A | 0000950170-23-015260 | 001-36687 | 23856819 | 34 | 4428683 | 1 | 1 | |
| 2023-03-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-021136 | 4525 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018508 | 5327 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018505 | 5366 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018501 | 5328 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018482 | 5348 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018476 | 5330 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018470 | 5294 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018467 | 5309 | ||||||
| 2023-03-14 | 8-K | 8-K | 5.02,9.01 | 0000950170-23-007858 | 001-36687 | 23730690 | 34 | 341761 | 1 | 1 |
| 2023-03-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-017636 | 18657 | ||||||
| 2023-03-08 | 8-K | 8-K | 8.01,9.01 | 0000950170-23-006719 | 001-36687 | 23716443 | 34 | 240026 | 1 | 1 |
| 2023-03-01 | 10-K | 10-K | 0000950170-23-005582 | 001-36687 | 23694282 | 34 | 12638995 | 1 | 1 | |
| 2023-03-01 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-005549 | 001-36687 | 23693827 | 34 | 480079 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, #2 | 0000899140-23-000395 | 005-88403 | 23629691 | 34 | 50226 | |||
| 2023-02-14 | SC 13G/A | XENON PHARMACEUTICALS, INC. | 0000902664-23-001690 | 005-88403 | 23623551 | 34 | 59609 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 13 TO THE SCHEDULE 13G | 0000921895-23-000486 | 005-88403 | 23621339 | 34 | 276640 | |||
| 2023-02-10 | SC 13G/A | schedule13g.htm | 0000938206-23-000009 | 005-88403 | 23609736 | 34 | 52288 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-002147 | 005-88403 | 23605179 | 34 | 8065 | |||
| 2022-12-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-060939 | 7144 | ||||||
| 2022-11-28 | 4 | FORM 4 SUBMISSION | 0001209191-22-058916 | 13789 | ||||||
| 2022-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-056248 | 5360 | ||||||
| 2022-11-09 | 3 | FORM 3 SUBMISSION | 0001209191-22-056243 | 7167 | ||||||
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023283 | 001-36687 | 221369488 | 34 | 9146726 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023202 | 001-36687 | 221368908 | 34 | 497229 | 1 | 1 |
| 2022-11-07 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-022588 | 001-36687 | 221365417 | 34 | 215158 | 1 | 1 |
| 2022-09-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-049015 | 25376 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-048508 | 24001 | ||||||
| 2022-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-046017 | 16436 | ||||||
| 2022-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-046015 | 14933 | ||||||
| 2022-08-09 | 10-Q | 10-Q | 0001564590-22-028780 | 001-36687 | 221148957 | 34 | 6507179 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-028750 | 001-36687 | 221148266 | 34 | 426728 | 1 | 1 |
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039837 | 5331 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039836 | 5451 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039833 | 5216 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039831 | 5435 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039829 | 5394 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039827 | 5368 | ||||||
| 2022-06-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-039824 | 5359 | ||||||
| 2022-06-23 | 424B5 | 424B5 | 0001564590-22-024069 | 333-260010 | 221035520 | 33 | 1356305 | |||
| 2022-06-23 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-024065 | 001-36687 | 221035435 | 34 | 854068 | 1 | 1 |
| 2022-06-22 | 424B5 | 424B5 | 0001564590-22-023893 | 333-260010 | 221032046 | 33 | 1293830 | |||
| 2022-06-21 | 8-K | 8-K | 8.01,9.01 | 0001564590-22-023664 | 001-36687 | 221026009 | 34 | 206996 | 1 | 1 |
| 2022-06-02 | S-8 | S-8 | 0001564590-22-022244 | 333-265377 | 22991044 | 33 | 236072 | |||
| 2022-06-02 | 8-K | 8-K | 5.02,5.07,9.01 | 0001564590-22-022228 | 001-36687 | 22990744 | 34 | 746597 | 1 | 1 |
| 2022-05-10 | 10-Q | 10-Q | 0001564590-22-019318 | 001-36687 | 22910606 | 34 | 5221492 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-019282 | 001-36687 | 22909829 | 34 | 348493 | 1 | 1 |
| 2022-04-28 | DEF 14A | DEF 14A | 0001564590-22-016439 | 001-36687 | 22866532 | 34 | 2125079 | |||
| 2022-03-22 | 8-K | 8-K | 3.02 | 0001564590-22-011356 | 001-36687 | 22759505 | 34 | 162780 | 1 | 1 |
| 2022-03-21 | SC 13G/A | AMENDMENT NO. 12 TO THE SCHEDULE 13G | 0000921895-22-000915 | 005-88403 | 22753877 | 34 | 277207 | |||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018467 | 5330 | ||||||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018463 | 5366 | ||||||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018457 | 5307 | ||||||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018453 | 5348 | ||||||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018449 | 5330 | ||||||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018445 | 5309 | ||||||
| 2022-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-018440 | 5312 | ||||||
| 2022-03-10 | 8-K | 8-K | 2.02,8.01,9.01 | 0001564590-22-009639 | 001-36687 | 22729152 | 34 | 224564 | 1 | 1 |
| 2022-03-08 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-017418 | 5200 | ||||||
| 2022-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-017341 | 42453 | ||||||
| 2022-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-017318 | 21495 | ||||||
| 2022-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-017316 | 25295 | ||||||
| 2022-03-01 | 424B5 | 424B5 | 0001564590-22-008105 | 333-260010 | 22699614 | 33 | 1168932 | |||
| 2022-03-01 | 8-K | 8-K | 1.01,9.01 | 0001564590-22-008072 | 001-36687 | 22698883 | 34 | 299523 | 1 | 1 |
| 2022-03-01 | 10-K | 10-K | 0001564590-22-008060 | 001-36687 | 22698562 | 34 | 9287955 | 1 | 1 | |
| 2022-03-01 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-008039 | 001-36687 | 22698132 | 34 | 352085 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 1) | 0000899140-22-000322 | 005-88403 | 22633294 | 34 | 54136 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 11 TO THE SCHEDULE 13G | 0000921895-22-000538 | 005-88403 | 22629139 | 34 | 282409 | |||
| 2022-02-14 | SC 13G | NONE | 0001567619-22-003820 | 005-88403 | 22626042 | 34 | 66379 | |||
| 2022-02-11 | SC 13G/A | AMENDMENT NO. 3 | 0000947871-22-000220 | 005-88403 | 22622583 | 34 | 59938 | |||
| 2022-02-11 | SC 13G/A | XENON PHARMACEUTICALS, INC. | 0000902664-22-001513 | 005-88403 | 22617299 | 34 | 58529 | |||
| 2022-02-10 | SC 13G/A | XENON PHARMACEUTICALS INC. | 0000902664-22-001405 | 005-88403 | 22612157 | 34 | 101510 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001252 | 005-88403 | 22604709 | 34 | 8325 | |||
| 2022-01-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-004460 | 4495 | ||||||
| 2022-01-12 | 8-K | 8-K | 3.02,8.01,9.01 | 0001564590-22-001074 | 001-36687 | 22525598 | 34 | 375984 | 1 | 1 |
| 2021-12-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-070231 | 7341 | ||||||
| 2021-12-10 | 4 | FORM 4 SUBMISSION | 0001209191-21-069018 | 8057 | ||||||
| 2021-12-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-068300 | 4498 | ||||||
| 2021-12-01 | 8-K | 8-K | 1.01,2.03,9.01 | 0001564590-21-058942 | 001-36687 | 211462880 | 34 | 1012027 | 1 | 1 |
| 2021-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-064931 | 5001 | ||||||
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-056248 | 001-36687 | 211397397 | 34 | 7100421 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-056197 | 001-36687 | 211396757 | 34 | 433232 | 1 | 1 |
| 2021-10-28 | SC 13G | SCHEDULE 13G | 0000899140-21-000694 | 005-88403 | 211359571 | 34 | 58015 | |||
| 2021-10-06 | 424B5 | 424B5 | 0001564590-21-050327 | 333-260010 | 211310343 | 33 | 1315658 | |||
| 2021-10-06 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-050322 | 001-36687 | 211310226 | 34 | 879860 | 1 | 1 |
| 2021-10-05 | FWP | FWP | 0000950123-21-012856 | 333-260010 | 211307182 | 34 | 110234 | |||
| 2021-10-04 | 424B5 | 424B5 | 0001564590-21-050074 | 333-260010 | 211304088 | 33 | 1228739 | |||
| 2021-10-04 | S-3ASR | S-3ASR | 0001564590-21-050016 | 333-260010 | 211302643 | 33 | 596414 | |||
| 2021-10-04 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-049880 | 001-36687 | 211300983 | 34 | 234432 | 1 | 1 |
| 2021-09-08 | 8-K | 8-K | 3.02,8.01,9.01 | 0001564590-21-047258 | 001-36687 | 211240804 | 34 | 384716 | 1 | 1 |
| 2021-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-21-053304 | 5359 | ||||||
| 2021-08-25 | 3 | FORM 3 SUBMISSION | 0001209191-21-053302 | 7172 | ||||||
| 2021-08-23 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-045346 | 001-36687 | 211195446 | 34 | 193935 | 1 | 1 |
| 2021-08-11 | 10-Q | 10-Q | 0001564590-21-043484 | 001-36687 | 211164105 | 34 | 6488501 | 1 | 1 | |
| 2021-08-11 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-043446 | 001-36687 | 211163628 | 34 | 434616 | 1 | 1 |
| 2021-06-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-038431 | 8950 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-038079 | 5558 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-038070 | 5542 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-038067 | 5493 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-038063 | 5475 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-038058 | 5466 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-038055 | 5501 | ||||||
| 2021-06-03 | 3 | FORM 3 SUBMISSION | 0001209191-21-038049 | 7139 | ||||||
| 2021-06-03 | 8-K | 8-K | 5.07,8.01 | 0001564590-21-031608 | 001-36687 | 21993659 | 34 | 259606 | 1 | 1 |
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-037707 | 5362 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-037692 | 5337 | ||||||
| 2021-06-03 | 3 | FORM 3 SUBMISSION | 0001209191-21-037672 | 14201 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036802 | 18889 | ||||||
| 2021-06-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-036798 | 19553 | ||||||
| 2021-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-21-035911 | 9433 | ||||||
| 2021-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-034400 | 15317 | ||||||
| 2021-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-034396 | 9039 | ||||||
| 2021-05-11 | 10-Q | 10-Q | 0001564590-21-026590 | 001-36687 | 21912011 | 34 | 5409724 | 1 | 1 | |
| 2021-05-11 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-026563 | 001-36687 | 21911546 | 34 | 369369 | 1 | 1 |
| 2021-04-28 | DEF 14A | DEF 14A | 0001564590-21-021327 | 001-36687 | 21864155 | 34 | 1739009 | |||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-020484 | 5327 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-020481 | 5366 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-020478 | 5298 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-020476 | 5348 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-020473 | 5312 | ||||||
| 2021-03-12 | 8-K | 8-K | 5.02,8.01,9.01 | 0001564590-21-012910 | 001-36687 | 21738363 | 34 | 239814 | 1 | 1 |
| 2021-03-10 | 424B5 | 424B5 | 0001564590-21-012120 | 333-238896 | 21730937 | 33 | 1278483 | |||
| 2021-03-10 | 8-K | 8-K | 8.01,9.01 | 0001564590-21-012118 | 001-36687 | 21730896 | 34 | 869750 | 1 | 1 |
| 2021-03-09 | 424B5 | 424B5 | 0001564590-21-011804 | 333-238896 | 21727016 | 33 | 1239384 | |||
| 2021-03-01 | 10-K | 10-K | 0001564590-21-009905 | 001-36687 | 21698571 | 34 | 10241348 | 1 | 1 | |
| 2021-03-01 | 8-K | 8-K | 2.02,5.02,9.01 | 0001564590-21-009839 | 001-36687 | 21697673 | 34 | 371290 | 1 | 1 |
| 2021-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-012039 | 17316 | ||||||
| 2021-02-16 | SC 13G/A | AMENDMENT NO. 10 TO THE SCHEDULE 13G | 0000921895-21-000397 | 005-88403 | 21631018 | 34 | 284363 | |||
| 2021-02-12 | SC 13G/A | AMENDMENT NO. 2 | 0000947871-21-000188 | 005-88403 | 21629588 | 34 | 69628 | |||
| 2021-02-12 | SC 13G/A | XENON PHARMACEUTICALS, INC. | 0000902664-21-001248 | 005-88403 | 21622936 | 34 | 58415 | |||
| 2021-02-11 | SC 13G/A | XENON PHARMACEUTICALS INC. | 0000902664-21-001138 | 005-88403 | 21616788 | 34 | 102958 | |||
| 2021-02-08 | SC 13G | filing.txt | 0000315066-21-001352 | 005-88403 | 21599871 | 34 | 8315 | |||
| 2021-01-14 | 8-K/A | 8-K/A | 5.02 | 0001564590-21-001141 | 001-36687 | 21527530 | 34 | 169590 | 1 | 1 |
| 2021-01-14 | 8-K | 8-K | 1.01,5.02,8.01,9.01 | 0001564590-21-001139 | 001-36687 | 21527527 | 34 | 861452 | 1 | 1 |
| 2020-12-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-063494 | 7230 | ||||||
| 2020-11-05 | 4 | FORM 4 SUBMISSION | 0001209191-20-057208 | 5547 | ||||||
| 2020-11-05 | 3 | FORM 3 SUBMISSION | 0001209191-20-057205 | 7230 | ||||||
| 2020-11-05 | 10-Q | 10-Q | 0001564590-20-051443 | 001-36687 | 201291391 | 34 | 6570807 | 1 | 1 | |
| 2020-11-05 | 8-K | 8-K | 2.02,5.02,9.01 | 0001564590-20-051310 | 001-36687 | 201290537 | 34 | 445947 | 1 | 1 |
| 2020-10-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-056229 | 12563 | ||||||
| 2020-10-29 | 4 | FORM 4 SUBMISSION | 0001209191-20-056222 | 7946 | ||||||
| 2020-09-01 | CT ORDER | filename1.pdf | 20200901,20200901 | 9999999997-20-004559 | 333-198666 | 201153440 | 33 | 123231 | ||
| 2020-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-20-048095 | 6136 | ||||||
| 2020-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-20-046974 | 5359 | ||||||
| 2020-08-17 | 3 | FORM 3 SUBMISSION | 0001209191-20-046970 | 7219 | ||||||
| 2020-08-17 | 8-K | 8-K | 8.01,9.01 | 0001564590-20-040375 | 001-36687 | 201108019 | 34 | 194180 | 1 | 1 |
| 2020-08-06 | 424B5 | 424B5 | 0001564590-20-037893 | 333-238896 | 201082781 | 33 | 885522 | |||
| 2020-08-06 | 8-K | 8-K | 1.01,9.01 | 0001564590-20-037867 | 001-36687 | 201082502 | 34 | 578935 | 1 | 1 |
| 2020-08-06 | 10-Q | XENE-10Q-20200806-Q2 | 0001564590-20-037862 | 001-36687 | 201082470 | 34 | 6603547 | 1 | 1 | |
| 2020-08-06 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-037751 | 001-36687 | 201081804 | 34 | 450055 | 1 | 1 |
| 2020-06-22 | SC 13G/A | AMENDMENT NO. 9 TO THE SCHEDULE 13G | 0000921895-20-001824 | 005-88403 | 20979598 | 34 | 284965 | |||
| 2020-06-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-06-12 16:30:00 | 9999999995-20-001418 | 333-238896 | 20961802 | 33 | 1681 | ||
| 2020-06-10 | 4 | FORM 4 SUBMISSION | 0001209191-20-035608 | 7094 | ||||||
| 2020-06-10 | CORRESP | filename1.htm | 0001564590-20-028884 | 13876 | ||||||
| 2020-06-10 | UPLOAD | filename1.pdf | 0000000000-20-005143 | 40116 | ||||||
| 2020-06-03 | S-3 | S-3 | 0001564590-20-028142 | 333-238896 | 20938934 | 33 | 567901 | |||
| 2020-06-03 | S-8 | S-8 | 0001564590-20-028139 | 333-238895 | 20938932 | 33 | 246489 | |||
| 2020-06-03 | 8-K | 8-K | 5.02,5.07,9.01 | 0001564590-20-028137 | 001-36687 | 20938922 | 34 | 577302 | ||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033669 | 9378 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033653 | 5323 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033643 | 5335 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033639 | 5558 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033627 | 5493 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033605 | 5475 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033596 | 5441 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033593 | 5466 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033588 | 10924 | ||||||
| 2020-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-033578 | 7254 | ||||||
| 2020-05-28 | 4 | FORM 4 SUBMISSION | 0001209191-20-032628 | 9699 | ||||||
| 2020-05-26 | 10-Q/A | 10-Q/A | 0001564590-20-026807 | 001-36687 | 20908020 | 34 | 2719760 | 1 | ||
| 2020-05-22 | 10-Q/A | 10-Q/A | 0001564590-20-026739 | 001-36687 | 20905913 | 34 | 228184 | 1 | ||
| 2020-05-21 | 10-Q | 10-Q | 0001564590-20-026574 | 001-36687 | 20902478 | 34 | 1749517 | |||
| 2020-05-21 | 8-K | 8-K | 2.02,9.01 | 0001564590-20-026545 | 001-36687 | 20901887 | 34 | 226797 | ||
| 2020-05-06 | 8-K | 8-K | 8.01 | 0001564590-20-021912 | 001-36687 | 20852578 | 34 | 41063 | ||
| 2020-04-28 | DEF 14A | DEF 14A | 0001564590-20-019198 | 001-36687 | 20824948 | 34 | 2031500 | |||
| 2020-03-13 | 4 | FORM 4 SUBMISSION | 0001209191-20-018969 | 5305 | ||||||
| 2020-03-13 | 4 | FORM 4 SUBMISSION | 0001209191-20-018963 | 5359 |
One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 98.28M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 2.40B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| ecd | AwardExrcPrice | AwardExrcPrice | USD/shares | 41.9 | 2025-10-15 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | |||
| ecd | AwardGrantDateFairValue | AwardGrantDateFairValue | USD | 5.81M | 2025-10-15 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | |||
| ecd | AwardUndrlygSecuritiesAmt | AwardUndrlygSecuritiesAmt | shares | 225,000 | 2025-10-15 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | |||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.56M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.57M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 120 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 291 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | ||
| ecd | UndrlygSecurityMktPriceChngPct | UndrlygSecurityMktPriceChngPct | Rate | -0.01 | 2025-10-15 | DEF 14A | 2026-04-22 | 0001193125-26-170320 | |||
| ffd | NetFeeAmt | NetFeeAmt | USD | 996.5 | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453723 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 996.5 | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453723 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 11.45M | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453723 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-11-09 | S-8 | 2026-11-09 | 0001193125-26-453723 | |||
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 8.65M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-069342 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 44.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 1.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 1.47M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 859,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125547 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 42.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 5.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 15.45M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -5.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 30.35M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 227.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 73,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 16.59M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 538,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 50.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 |
| us-gaap | AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits | Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units | USD | -5,000 | 2019-04-01 | 2019-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037862 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 12.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | Assets | Assets | USD | 1.20B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 960.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 1.15B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.96M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061200 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 1.07B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 1.07B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 868.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 202.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 82.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -30.68M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-06 | 0001564590-19-029418 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 82.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -116.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight | Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares | 1.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 1.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001564590-15-007290 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 98.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 98.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2.49B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -328.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 3.64M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008060 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 709,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009905 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 14.09M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 124,000 | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001564590-17-003716 |
| us-gaap | ConversionOfStockSharesConverted1 | Conversion of Stock, Shares Converted | shares | 7.73M | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 |
| us-gaap | CumulativeEffectOnRetainedEarningsNetOfTax1 | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | USD | -175,000 | 2019-01-01 | 2019-03-31 | 2020 | Q1 | 10-Q/A | 2020-05-26 | 0001564590-20-026807 |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 4.78M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 4.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 4.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 15.50M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 870.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent | USD | 204.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | DebtSecuritiesTradingUnrealizedGainLoss | Debt Securities, Trading, Unrealized Gain (Loss) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | DeferredCompensationShareBasedArrangementsLiabilityCurrent | Deferred Compensation Share-based Arrangements, Liability, Current | USD | 6.30M | 2015-03-31 | 2015 | Q1 | 10-Q/A | 2015-08-13 | 0001564590-15-007284 | |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | -8.86M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | DeferredFinanceCostsNoncurrentNet | Debt Issuance Costs, Noncurrent, Net | USD | 0 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | -3.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 15.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -2.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 164,000 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-13 | 0001564590-15-007290 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 11.78M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 157,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001564590-17-003716 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 157,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 983,000 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 361.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 19.65M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | DeferredTaxAssetsInvestments | Deferred Tax Assets, Investments | USD | 20.11M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 12.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 186,000 | 2020-03-31 | 2020 | Q1 | 10-Q/A | 2020-05-26 | 0001564590-20-026807 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 14.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 251.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 1.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 13.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 5.35M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 46.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 10.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 346.79M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 1.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.05 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 738,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.35 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019318 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.15 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.128 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.012 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0.003 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.013 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | USD | 326,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-06 | 0001564590-19-029418 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 75,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity | Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity | USD | 1.65M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 14.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 112.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ForeignCurrencyExchangeRateTranslation1 | Foreign Currency Exchange Rate, Translation | pure | 0.76 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023177 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | 95,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ForeignCurrencyTransactionGainLossUnrealized | Foreign Currency Transaction Gain (Loss), Unrealized | USD | 626,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | GainLossOnContractTermination | Gain (Loss) on Contract Termination | USD | 4.40M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | 11,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 72.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncentiveFromLessor | Incentive from Lessor | USD | 70,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001564590-17-003716 | |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -351.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -324.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 6.17M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 8.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -1.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 8.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 44.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | -1.44M | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -51.73M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 6.48M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023177 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 1.32M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 4.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 90,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 148,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023177 |
| us-gaap | IncomeTaxReconciliationTaxCreditsInvestment | Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Amount | USD | 2.87M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023177 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 158.63M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | 7.18M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-069342 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 4.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 614,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -3.64M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023177 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -157,000 | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004750 |
| us-gaap | IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option | USD | -133,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001564590-17-009917 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 77,000 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 131,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | -200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -331,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -230,000 | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-06 | 0001564590-19-029418 |
| us-gaap | IncrementalCommonSharesAttributableToContingentlyIssuableShares | Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares | shares | 12,277 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 1,680 | 2019-04-01 | 2019-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037862 |
| us-gaap | InterestExpense | Interest Expense | USD | 484,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 |
| us-gaap | InterestIncomeDepositsWithFinancialInstitutions | Interest Income, Deposits with Financial Institutions | USD | 3.52M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-01 | 0001564590-22-008060 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 71,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011901 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 30.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.19M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 6.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 1.82M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 452,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 612,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | Liabilities | Liabilities | USD | 53.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.20B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 45.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 31,000 | 2017-01-01 | 2017-06-30 | 2018 | Q2 | 10-Q | 2018-08-07 | 0001564590-18-020018 |
| us-gaap | LicensesRevenue | Licenses Revenue (Deprecated 2018-01-31) | USD | 12.35M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010362 |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 4.65M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009905 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 4.65M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 4.13M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027475 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 4.13M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040449 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 4.65M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 6.20M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 700,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011901 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 10.89M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001564590-21-009905 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 868.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 202.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 667,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -4.65M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001564590-22-028780 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 843.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 119,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011901 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -685.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 4.98M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011901 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -274.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -8.22M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011901 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -323.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -234.33M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -7.44M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037862 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 30.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 355.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -355.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 6.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 4.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 5.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 993,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 3.58M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.13M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 279,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004750 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 256,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.07M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.13M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 1.27M | 2015-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.036 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 932.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -5.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -3.50M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001564590-17-003716 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -2.40M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 24.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 3.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 1.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 12.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic | Participating Securities, Distributed and Undistributed Earnings (Loss), Basic | USD | 8.20M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.53M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001564590-17-003716 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 1.17B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 692,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 | |
| us-gaap | PreferredStockShareSubscriptions | Preferred Stock, Shares Subscribed but Unissued | shares | 0 | 2014-11-10 | 2015 | Q1 | 10-Q/A | 2015-08-13 | 0001564590-15-007284 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 7.73M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 8.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 9.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 7.97M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-338244 | |
| us-gaap | PriorPeriodReclassificationAdjustment | Prior Period Reclassification Adjustment | USD | 1.48M | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-11 | 0000950170-25-106599 |
| us-gaap | ProceedsFromDebtNetOfIssuanceCosts | Proceeds from Debt, Net of Issuance Costs | USD | 8.45M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 |
| us-gaap | ProceedsFromInterestReceived | Proceeds from Interest Received | USD | 550,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-10 | 0001564590-15-010362 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 12.08M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 29.51M | 2023-01-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125547 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 35,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023177 |
| us-gaap | ProceedsFromRepaymentsOfDebt | Proceeds from (Repayments of) Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-01 | 0000950170-23-005582 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 481.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 10,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 5.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -323.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 7.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 1.70M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-08 | 0001564590-16-014222 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 283.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.57B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 311,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-06 | 0001564590-19-006514 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | RevenueRecognitionMilestoneMethodRevenueRecognized | Revenue Recognition, Milestone Method, Revenue Recognized | USD | 23.49M | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-12-15 | 0001171843-14-005910 |
| us-gaap | Revenues | Revenues | USD | 311,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004750 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 3.02M | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | RoyaltyRevenue | Royalty Revenue (Deprecated 2018-01-31) | USD | 2,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004750 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | -1.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 50.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 210,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125547 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-125547 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.58 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.038 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 103.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 6.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 32.02 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 28.44M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 170,167 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 39.21 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 24.35 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 4.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 515,289 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | USD/shares | 25.39 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 22.62 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 137.66M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 11.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 36 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 722,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 56.97M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 2.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 24.09 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 23.94 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 43.28 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 6.47M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 1.15B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 4.86 | 2014-10-01 | 2014 | FY | 10-K | 2015-03-12 | 0001564590-15-001612 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 21.82M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 1.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 102.49M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-08 | 0001564590-17-003716 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 112.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationGross | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | USD | 228,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 47,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 |
| us-gaap | StockRedeemedOrCalledDuringPeriodValue | Stock Redeemed or Called During Period, Value | USD | -4.47M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-09 | 0001564590-20-009385 |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 106,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 | |
| us-gaap | TradingSecuritiesDebt | Debt Securities, Trading | USD | 13.87M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029149 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 13.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 747,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 588,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 2.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 5,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 2.45M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 79.94M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-076650 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 652,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 95.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 54.85M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019318 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 95.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-453701 |